TrademarkDir
ORYZA PHARMACEUTICALS INC.
LIVE

Serial Number

97009108

Owner

Oryza Pharmaceuticals, Inc.

Attorney

E. Anthony Figg

First Use Date

Mar 15, 2016

Filing Date

Sep 2, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ORYZA PHARMACEUTICALS INC. Trademark

Serial Number: 97009108 • Registration: 8026799

ORYZA PHARMACEUTICALS INC. is a trademark filed by Oryza Pharmaceuticals, Inc. on September 2, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oryza Pharmaceuticals, Inc. (4 trademarks)

4117 NW 124th Ave
Coral Springs, FL 33065

Entity Type: 03

Trademark Details

Filing Date

September 2, 2021

Registration Date

November 18, 2025

First Use Anywhere

March 15, 2016

First Use in Commerce

March 15, 2016

Published for Opposition

August 26, 2025

Goods & Services

Pharmaceutical research and development; Development of pharmaceutical preparations and medicines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 31, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Oct 31, 2025 IUCN
POST PUBLICATION AMENDMENT - ENTERED
Oct 29, 2025 CHPB
ASSIGNED TO PETITION STAFF
Oct 29, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 23, 2025 EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 23, 2025 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 22, 2025 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2025 CNEA
EXPARTE APPEAL TERMINATED
Jul 14, 2025 EXPT
EX PARTE APPEAL-REFUSAL AFFIRMED
Apr 14, 2025 EXPA
REPLY BRIEF FILED - CHECK TTAB FILES
Feb 28, 2025 RBFT
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Feb 7, 2025 GNSN
EXAMINERS STATEMENT E-MAILED
Feb 7, 2025 GNES
EXAMINERS STATEMENT - COMPLETED
Feb 7, 2025 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 12, 2024 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jun 11, 2024 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jun 11, 2024 GECD
ACTION CONTINUING FINAL - COMPLETED
Jun 11, 2024 CNCF
EX PARTE APPEAL-INSTITUTED
Feb 8, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 8, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 8, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Nov 9, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Nov 9, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 10, 2023 GNFN
FINAL REFUSAL E-MAILED
Aug 10, 2023 GNFR
FINAL REFUSAL WRITTEN
Aug 10, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 14, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 14, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2022 CNRT
ASSIGNED TO EXAMINER
May 31, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2021 NWOS
NEW APPLICATION ENTERED
Sep 6, 2021 NWAP

Related Trademarks

More from this Owner

ORYZA HEALTH SCIENCES

ORYZA HEALTH SCIENCES

ORYZA LIFE SCIENCES

ORYZA LIFE SCIENCES

ORYZA HEALTHY

ORYZA HEALTHY